Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$783,600
+$19,850 QoQ
Shares Held
5,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
4.44%
of 13F equity value
Holder Rank
#706
of 1,603 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Payne Capital LLC holds $3,134,686 across 4 Drug Manufacturers - General names. NVS ranks #2 (25.0% of the industry book) .
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $783,600 | 5,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $763,750 | 5,000 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $689,350 | 5,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $641,200 | 5,000 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||